Phosplatin Therapeutics releases Phase 1b results for PT-112/avelumab combo
AbbVie and I-Mab collaborate on lemzoparlimab
Special Report on Stem Cells: Mother lode
Hopes on the rise in wake of ASCENT data
Critical for cancer
A (natural) killer match
ISA101b and Libtayo vs. oropharyngeal cancer
An ESR1 evaluation
Regional rights for taletrectinib
Gaining ground with Gemini
Tracking down gene fusions
New tool predicts patients’ immunotherapy response
Qu Biologics takes SSIs to Phase 2
Research discovers how platelets initiate ovarian cancer metastasis
Secura acquires Copiktra from Verastem
Recurring HRAS mutation may drive head and neck cancers
FDA approves Tecartus for mantle cell lymphoma
TAPS aims for gold (standard)
Signature, please
FDA gives thumbs up to Agilent’s CDx
NMPA approves Optune for glioblastoma
On the cutting edge
Upregulating to success
TBR-760 halts tumor growth in mice
New insights in cell biology
Clarifying cell function
Mapping migration
OSE brings CLEC-1 to AACR
Examining ELP1
A boost to sorafenib?
Focus Feature: Cancer Research News
Oncology--Stem to stern
A look at gastroesophageal, gastric and colorectal cancer progress
Focus Feature: Cancer Research News
Hitting the target
It’s never just been about killing or removing tumors; it’s about aiming at them accurately
Special Report on Cancer
Metabolic renaissance?
Drilling to the core of life itself: Researchers go deep into the world of metabolomics to find new therapeutic possibilities with metabo-oncology
PAGE UTILITIES
PRINT CURRENT PAGE
SEND THIS PAGE TO A COLLEAGUE
CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 | Fax: 705-528-0270
Home
|
About Us
|
Editor's Choice
|
News
|
Opinion
|
Top 5
|
Video
|
Links
© Copyright 2020 Old River Publications LLC. All righs reserved. | Web site managed and designed by
OffWhite.
